Related Experiment Video
Updated: Aug 6, 2026
07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 2, 2013
Current state of immunotherapy for bladder cancer
Wassim Kassouf1, Ashish M Kamat
1Department of Urology, Unit 446, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. kasso98@hotmail.com
Expert Review of Anticancer Therapy
|December 21, 2004
Summary
Bacillus Calmette-Guerin (BCG) is a highly effective immunotherapy for superficial bladder cancer. Combining BCG with interferon-alpha2b offers a promising salvage therapy for patients unresponsive to initial treatments.
Area of Science:
- Urology
- Immunotherapy
- Oncology
Background:
- Superficial bladder cancer treatment relies heavily on Bacillus Calmette-Guerin (BCG) immunotherapy.
- BCG was approved by the US FDA in 1990 for carcinoma in situ of the bladder.
- Refractory cases necessitate exploring advanced therapeutic strategies.
Purpose of the Study:
- To review the role of immunotherapeutic agents in bladder cancer treatment.
- To emphasize appropriate Bacillus Calmette-Guerin (BCG) administration and scheduling.
- To highlight salvage therapy combining BCG with interferon-alpha2b.
Main Methods:
- Literature review of immunotherapeutic agents for bladder cancer.
- Analysis of Bacillus Calmette-Guerin (BCG) therapy protocols.
- Evaluation of combination therapies, specifically BCG with interferon-alpha2b.
Main Results:
- Bacillus Calmette-Guerin (BCG) remains the most effective agent for superficial bladder cancer.
- Augmentation of BCG immunotherapy with interferon-alpha2b is an emerging salvage option.
- Optimal administration and scheduling of BCG are crucial for efficacy.
Conclusions:
- Bacillus Calmette-Guerin (BCG) is a cornerstone in superficial bladder cancer treatment.
- Combination immunotherapy with BCG and interferon-alpha2b shows potential as salvage therapy.
- Further research into optimized immunotherapy regimens is warranted.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...